Certara’s Patient Services Strategy offering is flexible based on your budget and project type, and focused on helping biopharma companies design impactful programs that…
Certara’s Model-Informed Drug Development (MIDD) approach leverages an integrated, quantitative systems methodology to accelerate regulatory approval and commercial success while…
The American Thrombosis and Hemostasis Network (ATHN), a not-for-profit organization, has been improving care and advancing research for individuals with…
